![Tom Galli](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tom Galli
Direttore/Membro del Consiglio presso LUNGevity Foundation
Profilo
Tom Galli is currently the Director at LUNGevity Foundation since 2018.
He has an undergraduate degree from the University of Dayton and another undergraduate degree from Defense Systems Management College.
Posizioni attive di Tom Galli
Società | Posizione | Inizio |
---|---|---|
LUNGevity Foundation
![]() LUNGevity Foundation Miscellaneous Commercial ServicesCommercial Services LUNGevity Foundation is a lung cancer organization that aims to improve the quality of life and survivorship of those affected by the disease. The non-profit company is based in Chicago, IL. The company address disparities in care and promotes health equity through research, advocacy, and community support. The company's approach includes finding lung cancer earlier, advancing research into new treatments, and ensuring a diverse pipeline of investigators. The company also provides comprehensive resources such as a patient-centric website, patient gateways, a toll-free helpline, survivor conferences, and tools to find clinical trials. The CEO of the company is Andrea Stern Ferris. | Direttore/Membro del Consiglio | 09/05/2018 |
Formazione di Tom Galli
Defense Systems Management College | Undergraduate Degree |
University of Dayton | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
LUNGevity Foundation
![]() LUNGevity Foundation Miscellaneous Commercial ServicesCommercial Services LUNGevity Foundation is a lung cancer organization that aims to improve the quality of life and survivorship of those affected by the disease. The non-profit company is based in Chicago, IL. The company address disparities in care and promotes health equity through research, advocacy, and community support. The company's approach includes finding lung cancer earlier, advancing research into new treatments, and ensuring a diverse pipeline of investigators. The company also provides comprehensive resources such as a patient-centric website, patient gateways, a toll-free helpline, survivor conferences, and tools to find clinical trials. The CEO of the company is Andrea Stern Ferris. | Commercial Services |
- Borsa valori
- Insiders
- Tom Galli